El Tegaserod es un fármaco agonista parcial de los receptores de serotonina 5-HT4, desarrollado por Novartis.
| Property | Value |
|---|---|
| dbo:abstract |
|
| dbo:wikiPageID |
|
| dbo:wikiPageLength |
|
| dbo:wikiPageRevisionID |
|
| prop-es:c |
|
| prop-es:chembl |
|
| prop-es:chemspiderid |
|
| prop-es:drugbank |
|
| prop-es:embarazoAu |
|
| prop-es:embarazoUs |
|
| prop-es:h |
|
| prop-es:imagen |
|
| prop-es:inchi |
|
| prop-es:inchikey |
|
| prop-es:kegg |
|
| prop-es:n |
|
| prop-es:nombreIupac |
|
| prop-es:númeroCas |
|
| prop-es:o |
|
| prop-es:pesoMolecular |
|
| prop-es:prefijoAtc |
|
| prop-es:pubchem |
|
| prop-es:smiles |
|
| prop-es:stdinchi |
|
| prop-es:stdinchikey |
|
| prop-es:sufijoAtc |
|
| prop-es:unii |
|
| dct:subject | |
| rdf:type | |
| rdfs:comment |
|
| rdfs:label |
|
| owl:sameAs | |
| prov:wasDerivedFrom | |
| foaf:isPrimaryTopicOf | |
| is dbo:wikiPageRedirects of | |
| is prop-es:productos of | |
| is owl:sameAs of | |
| is foaf:primaryTopic of |
